VP/Head of Cell Therapy Franchise - Resilience:
“Vincent Mackay is a pro recruiter, worked closely and diligently with myself and the company to make my new position possible in the best fashion.”
RESILIENCE (National Resilience, Inc.) is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.
Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale.
RESILIENCE will offer the highest quality and regulatory capabilities, and flexible and adaptive facilities to serve partners of all sizes. By continuously advancing the science of biopharmaceutical manufacturing and development, RESILIENCE frees partners to focus on the discoveries that improve patients’ lives.
To find out more about Resilience contact Oliver Masson, Senior Account Manager (CDMO, Large Molecule) at Mantell Associates, on +44 (0)20 3778 0990 or oliver.masson@mantellassociates.com.